LEADER 03847oam 2200649I 450 001 9910787962803321 005 20230801231837.0 010 $a0-429-24843-1 010 $a1-4398-9610-0 010 $a1-4398-5315-0 024 7 $a10.1201/b15766 035 $a(CKB)2670000000557399 035 $a(EBL)1446978 035 $a(SSID)ssj0001039587 035 $a(PQKBManifestationID)11668231 035 $a(PQKBTitleCode)TC0001039587 035 $a(PQKBWorkID)10990304 035 $a(PQKB)10746063 035 $a(MiAaPQ)EBC1446978 035 $a(Au-PeEL)EBL1446978 035 $a(CaPaEBR)ebr11166175 035 $a(OCoLC)908077707 035 $a(OCoLC)892786767 035 $a(EXLCZ)992670000000557399 100 $a20180331d2012 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 10$aEssentials of law and ethics for pharmacy technicians /$fKenneth M. Strandberg 205 $aThird edition. 210 1$aBoca Raton, Fla. :$cCRC Press,$d2012. 215 $a1 online resource (184 p.) 225 1 $aPharmacy Education Series ;$v26 300 $aDescription based upon print version of record. 311 $a1-4398-5316-9 327 $aFront Cover; Contents; Preface; Acknowledgments; Authors; The legal system in the United States; Chapter 2: History and development of current law; Chapter 3: Food, Drug, and Cosmetic Act of 1938; Chapter 4: Federal Controlled Substance Act of 1970; Chapter 5: Other pertinent federal legislation; Chapter 6: Ethics theory and application; appendix one: Addresses and websites of board of pharmacy executives; appendix two: Addresses and websites of pertinent pharmacy organizations; appendix three: List of accredited pharmacy technician programs; appendix four: Sample DEA forms 327 $aappendix five: Legal standing of pharmacy techniciansappendix six: Legal status of fax prescriptions; appendix seven: Legal status of electronic transmission of prescriptions; appendix eight: Who has prescribing authority; Back Cover 330 $aPreface While many excellent textbooks deal with pharmacy laws, regulations, and ethics, virtually all of those currently marketed are aimed at the university-level pharmacy student. During my years as a faculty member and as a department chair, the lack of textbooks intended for pharmacy technicians became more and more noticeable, especially after visiting with pharmacy technician faculty and our colleagues at Pharmacy Technician Educator's Council (PTEC) meetings. The standard practice has been to incorporate law and ethics material into other classes, using parts of these university-level textbooks and articles and adding extra lecture time and materials. Very few programs have a stand-alone law and ethics course or even a segment of such a course, which can perhaps be explained by the fact that so few texts have been aimed at this need. Instructors have been forced to make do with materials and resources meant for an entirely different group of students--$cProvided by publisher. 410 0$aCRC Press pharmacy education series ;$v26. 606 $aPharmacy technicians$xProfessional ethics$zUnited States 606 $aPharmacists$xLegal status, laws, etc$zUnited States 606 $aPharmacy$xLaw and legislation$zUnited States 615 0$aPharmacy technicians$xProfessional ethics 615 0$aPharmacists$xLegal status, laws, etc. 615 0$aPharmacy$xLaw and legislation 676 $a344.7304/16 686 $aLAW093000$aMED071000$aMED072000$2bisacsh 700 $aStrandberg$b Kenneth M.$01573632 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910787962803321 996 $aEssentials of law and ethics for pharmacy technicians$93849444 997 $aUNINA LEADER 05615nam 2200733Ia 450 001 9911019952203321 005 20250418091453.0 010 $a9780977888214 010 $a9780470623992 010 $a0470623993 010 $a9780470623985 010 $a0470623985 035 $a(CKB)2550000000005923 035 $a(EBL)477717 035 $a(SSID)ssj0000353869 035 $a(PQKBManifestationID)11258807 035 $a(PQKBTitleCode)TC0000353869 035 $a(PQKBWorkID)10288276 035 $a(PQKB)11101524 035 $a(MiAaPQ)EBC3058081 035 $a(MiAaPQ)EBC477717 035 $a(Au-PeEL)EBL477717 035 $a(OCoLC)501316336 035 $a(EXLCZ)992550000000005923 100 $a20081017d2008 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 00$aPrimer on the metabolic bone diseases and disorders of mineral metabolism 205 $a7th ed. 210 $aWashington, D.C. $cAmerican Society for Bone and Mineral Research$dc2008 215 $a1 online resource (558 p.) 300 $aDescription based upon print version of record. 311 08$a9780977888214 311 08$a0977888215 320 $aIncludes bibliographical references and index. 327 $aPrimer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism; Contents; Section I. Molecular Cellular and Genetic Determinants of Bone Structure and Formation; 1. Skeletal Morphogenesis and Embryonic Development; 2. Signal Transduction Cascades Controlling Osteoblast Differentiation; 3. Osteoclast Biology and Bone Resorption; 4. Osteocytes; 5. Connective Tissue Pathways That Regulate Growth Factors; 6. The Composition of Bone; 7. Assessment of Bone Mass and Microarchitecture in Rodents; 8. Animal Models: Genetic Manipulation; 9. Animal Models: Allelic Determinants for BMD 327 $a10. Neuronal Regulation of Bone Remodeling11. Skeletal Healing; 12. Biomechanics of Fracture Healing; Section II. Skeletal Physiology; 13. Fetal and Neonatal Bone Development; 14. Skeletal Development in Childhood and Adolescence; 15. Ethnic Differences in Bone Acquisition; 16. Calcium and Other Nutrients During Growth; 17. Growing a Healthy Skeleton: The Importance of Mechanical Loading; 18. Pregnancy and Lactation; 19. Menopause; 20. Age-Related Bone Loss; Section III. Mineral Homeostasis; 21. Regulation of Calcium and Magnesium; 22. Fetal Calcium Metabolism; 23. Fibroblast Growth Factor-23 327 $a24. Gonadal Steroids25. Parathyroid Hormone; 26. Parathyroid Hormone-Related Protein; 27. Ca2+-Sensing Receptor; 28. Vitamin D: Production, Metabolism, Mechanism of Action, and Clinical Requirements; Section IV. Investigation of Metabolic Bone Diseases; 29. DXA in Adults and Children; 30. Quantitative Computed Tomography in Children and Adults; 31. Magnetic Resonance Imaging of Bone; 32. Radionuclide Scintigraphy in Metabolic Bone Disease; 33. Assessment of Fracture Risk; 34. Biochemical Markers of Bone Turnover in Osteoporosis; 35. Bone Biopsy and Histomorphometry in Clinical Practice 327 $a36. Vertebral Fracture Assessment37. Molecular Diagnosis of Bone and Mineral Disorders; Section V. Osteoporosis; 38. Epidemiology of Osteoporotic Fractures; 39. Overview of Pathogenesis; 40. Nutrition and Osteoporosis; 41. Role of Sex Steroids in the Pathogenesis of Osteoporosis; 42. Genetics of Osteoporosis; 43. Overview of Osteoporosis Treatment; 44. Prevention of Falls; 45. Orthopedic Surgical Principles of Fracture Management; 46. Exercise and the Prevention of Osteoporosis; 47. Calcium and Vitamin D; 48. Estrogens and SERMS; 49. Bisphosphonates for Postmenopausal Osteoporosis 327 $a50. Strontium Ranelate in the Prevention of Osteoporotic Fractures51. Parathyroid Hormone Treatment for Osteoporosis; 52. Calcitonin; 53. Combination Anabolic and Antiresorptive Therapy for Osteoporosis; 54. Compliance and Persistence With Osteoporosis Medications; 55. Cost-Effectiveness of Osteoporosis Treatment; 56. Future Therapies for Osteoporosis; 57. Juvenile Osteoporosis; 58. Glucocorticoid-Induced Osteoporosis; 59. Inflammation-Induced Bone Loss in the Rheumatic Diseases; 60. Osteoporosis: Other Secondary Causes; 61. Transplantation Osteoporosis; 62. Osteoporosis in Men 327 $a63. Premenopausal Osteoporosis 330 $aEDITOR-IN-CHIEF:Clifford J. Rosen, M.D., Maine Medical Center Research Institute, Scarborough, Maine SENIOR ASSOCIATE EDITORS:Juliet E. Compston, M.D., FRCP, University of Cambridge School of Clinical Medicine, Cambridge, United Kingdom Jane B. Lian, Ph.D., University of Massachusetts Medical School, Worcester, Massachusetts This comprehensive yet concise handbook is an indispensable reference for the many clinicians who see patients with disorders of bone formation, metabolic bone diseases, or disorders of stone formation. It is also a crucial tool for resea 606 $aBones$xMetabolism$xDisorders 606 $aMineral metabolism$xDisorders 606 $aBones$xDiseases 615 0$aBones$xMetabolism$xDisorders. 615 0$aMineral metabolism$xDisorders. 615 0$aBones$xDiseases. 676 $a616.7 676 $a616.7/16 676 $a616.71 676 $a616.716 701 $aRosen$b Clifford J$0878534 712 02$aAmerican Society for Bone and Mineral Research. 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9911019952203321 996 $aPrimer on the metabolic bone diseases and disorders of mineral metabolism$93064888 997 $aUNINA LEADER 03273nam 2200709Ia 450 001 9910974132803321 005 20251117013235.0 010 $a1-136-90310-0 010 $a1-136-90311-9 010 $a1-282-88233-3 010 $a9786612882333 010 $a0-203-84206-5 024 7 $a10.4324/9780203842065 035 $a(CKB)2670000000048632 035 $a(EBL)589632 035 $a(OCoLC)689996510 035 $a(SSID)ssj0000442633 035 $a(PQKBManifestationID)11925838 035 $a(PQKBTitleCode)TC0000442633 035 $a(PQKBWorkID)10465386 035 $a(PQKB)11568180 035 $a(MiAaPQ)EBC589632 035 $a(Au-PeEL)EBL589632 035 $a(CaPaEBR)ebr10422043 035 $a(CaONFJC)MIL288233 035 $a(OCoLC)699487826 035 $a(OCoLC)1257370960 035 $a(FINmELB)ELB160557 035 $a(EXLCZ)992670000000048632 100 $a20100402d2010 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 14$aThe South Sea Bubble $ean economic history of its origins and consequences /$fHelen J. Paul 205 $a1st ed. 210 $aLondon ;$aNew York $cRoutledge$d2010 215 $a1 online resource (176 p.) 225 0 $aRoutledge explorations in economic history The South Sea Bubble 300 $aDescription based upon print version of record. 311 08$a0-415-70839-7 311 08$a0-415-46973-2 320 $aIncludes bibliographical references (pages [135]-148) and index. 327 $aBook Cover; Title; Copyright; Contents; Figures; Acknowledgements; Notes on the text; Timeline; Abbreviations; 1 Introduction; 2 The stock market in early modern England; 3 Politics, warfare and finance; 4 Financial innovation and trade; 5 The Bubble and the crash; 6 Reasons to invest in the South Sea Company; 7 Criticism and financial complexity; 8 The social history of the crash; 9 The real effects of the crash; 10 Conclusion; Glossary; Notes; Bibliography; Index 330 $aThe book is an economic history of the South Sea Bubble. It combines economic theory and quantitative analysis with historical evidence in order to provide a rounded account. It brings together scholarship from a variety of different fields to update the existing historical work on the Bubble. Up until now, economic history research has not been integrated into mainstream histories of 1720. Technical work on share prices and ledgers has been inaccessible to a wider audience. As well as providing new evidence against the gambling mania argument, the book also interprets the existing economic 410 0$aRoutledge explorations in economic history ;$v49. 606 $aSouth Sea Bubble, Great Britain, 1720 606 $aFinancial crises$zGreat Britain$xHistory$y18th century 606 $aFinance$zGreat Britain$xHistory$y18th century 615 0$aSouth Sea Bubble, Great Britain, 1720. 615 0$aFinancial crises$xHistory 615 0$aFinance$xHistory 676 $a330.941/071 700 $aPaul$b Helen J.$f1975-$01874695 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910974132803321 996 $aThe South Sea Bubble$94485400 997 $aUNINA